Efficacy of Single Tocilizumab Administration in an 88-Year-Old Patient with Severe COVID-19 and a Mini Literature Review

Efficacy of Single Tocilizumab Administration in an 88-Year-Old Patient with Severe COVID-19 and a Mini Literature Review

The new coronavirus disease 2019 (COVID-19) could be associated with elevated inflammatory cytokine levels, suggesting the involvement of cytokine release syndrome. This syndrome is characterized by release of interleukin 6 correlated with COVID-19 severity and mortality. Targeting IL-6 with Tociliz...

Full description

Bibliographic Details
Main Authors: Cid Ould Ouali, Nadia Ladjouzi, Khidher Tamas, Hendriniaina Raveloson, Jihene Ben Hassen, Nesrine El Omeiri, Georges Zouloumis, Mohamed Moataz Al Zoabi, Muneer Asadi, Aziza Jhouri, Joël Schlatter
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Geriatrics
Subjects:
COVID-19
Tocilizumab
case report
elderly
inflammatory syndrome
Online Access:https://www.mdpi.com/2308-3417/7/1/22

Internet

https://www.mdpi.com/2308-3417/7/1/22

Similar Items